ResMed's (NYSE:RMD) stock up by 3.2% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be ...

The market expects Sherwin-Williams (SHW) to deliver a year-over-year increase in earnings on higher revenues when it reports ...

Another blue chip ASX share I would happily build a portfolio around is REA Group. Its property platforms sit at the centre ...

ResMed CEO Mick Farrell has become the first leader from the home care sector to chair the board of directors at AdvaMed, the trade association representing major medtech companies.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

These shares have smashed the market and look well-placed to continue this trend. The post 3 unstoppable ASX 200 shares to buy and hold forever appeared first on The Motley Fool Australia.

Based on Resmed’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.34 billion and a net profit of $348.54 million. In comparison, last year ...

Shares to open higher; DroneShield targets 50 per cent civilian revenue split; $A hits US69.40¢; gold tops $US5100; Alkane ...

Detailed price information for Telix Pharmaceutical Ltd (TLPPF) from The Globe and Mail including charting and trades.

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

For most people in the Philippines, sleep usually takes a back seat to work, school, and family obligations. Long commutes ...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Finding the right balance between safety and ...